Clinical trial results show that pregnant women with obesity can support fetal development without excess calorie intake. The study's findings suggest maintaining pre-pregnancy calorie intake and improving diet quality instead of increasing daily calorie consumption.
A new study has found that HIV can be detected in the central nervous system of patients on long-term antiretroviral therapy, linked to poorer cognitive performance. The discovery highlights the need to address viral mechanisms of cognitive decline in cART-treated patients.
A subpopulation of PD-1-expressing NK cells within tumors responds to checkpoint blockade, activating anti-cancer effects. These cells contribute significantly to the efficacy of checkpoint-targeting immunotherapies, suggesting new strategies for improving treatment outcomes.
Researchers found that low PUMA expression distinguishes stem-like cells in cancer patients who experienced tumor recurrence. Reducing PUMA restores metastasis in cultured cells, highlighting a possible Achilles heel in aggressive breast cancers.
Researchers have discovered a class of compounds that selectively inhibit fibrosis-initiating TGF-β pathways in fibroblasts, without affecting non-fibrogenic cells. These trihydroxyphenolic compounds may provide an opportunity to treat fibrosis with fewer side effects.
A recent study found that tumor-infiltrating immune cells, specifically regulatory T cells (Tregs), can interfere with immune-targeting therapies in aggressive breast cancers. Depleting Tregs delayed tumor growth in mouse models, suggesting a potential strategy to improve targeted treatments.
A study adapts a noninvasive retinal imaging approach to detect and quantify amyloid-β plaques in AD patients and healthy controls, revealing increased deposits in AD patients. This technology has the potential to enable significant advances in early detection and treatment of Alzheimer's disease.
Teriparatide therapy increases osteoblast activity and lifespan, but stopping treatment leads to increased fat cell formation in mice. This suggests therapies targeting parathyroid hormone receptors may prioritize osteoblast development over other cell fates.
A new gene mutation, RFWD3, has been linked to defective DNA repair and Fanconi anemia, a rare genetic disorder. The mutation was found in a 12-year-old patient without known Fanconi anemia genes, and cells from the patient showed increased susceptibility to DNA damage.
Researchers identified two proteins derived from common gut bacteria that trigger immune responses in RA patients, supporting a link between intestinal and synovial autoimmunity. The discovery provides a potential pathway for improving diagnosis and treatment of rheumatoid arthritis.
Family members of individuals with non-alcoholic fatty liver disease (NAFLD) and cirrhosis are at a significantly higher risk of developing advanced liver fibrosis. A clinical trial found that immediate relatives had 12 times higher prevalence of liver fibrosis than healthy controls, indicating the need for screenings in family members.
Macrophages from CAD patients suppress T cell activation, driven by pyruvate and PD-L1. This mechanism may contribute to immune dysfunction and reactivation of long-latent viruses like varicella zoster virus.
Researchers have developed a novel photoswitch that restores visual function in blind mice by activating retinal neurons. The light-sensitive molecule, DAD, targets bipolar cells, offering advantages over previous approaches. This breakthrough provides a promising alternative for treating vision loss.
A study led by Bernd Schnabl found that chronic alcohol intake increases fungal populations in the intestine and levels of β-glucan in the bloodstream, leading to liver inflammation. Treating mice with anti-fungal agents prevented liver disease, supporting further research into the fungal microbiome's role in alcohol-related liver damage.
Researchers discovered that residual tumor cells display alterations in fat metabolism and oxidative stress, which contribute to DNA damage and cancer relapse. Targeting metabolic pathways in these cells could potentially prevent recurrence.
Hyperglycemia triggers platelet production through the RAGE pathway, increasing atherosclerosis risk in diabetes. A study found that blocking RAGE receptor signaling reduced platelet production and atherogenesis.
Reducing glucocorticoid steroid frequency improves muscle recovery and function in mouse models of Duchenne muscular dystrophy. Intermittent dosing regimens may prevent debilitating side effects while preserving therapeutic effects on muscle function.
Researchers at Duke University discovered that CYP17A1 inhibitors function as competitive AR antagonists, indicating a more effective role in treating prostate cancer. The study found that these inhibitors can inhibit the growth of prostate tumor cells expressing treatment-resistant AR mutations.
Researchers developed a biopolymer delivery system combining CAR T cells and STING agonists to eliminate tumors more effectively than CAR T cell therapy alone. The method improved targeting of solid tumors, reducing metastasis, and providing promising support for combined immunotherapy approaches.
A study found that imbalances in neural pathways may contribute to repetitive behaviors in autism. Researchers discovered a key gene, SHANK3, which guides synaptic development and function, and its deficiency led to repetitive grooming behavior and social interaction deficits.
Research identifies PPARγ as a critical regulator of metabolism-associated genes in the liver. Inhibition of PPARγ suppresses tumor growth and reduces tumorigenesis in mouse models.
Research suggests that omega-3 fatty acids can diminish inflammatory processes contributing to type 1 diabetes. Increasing omega-3 FA consumption improved glucose metabolism and reduced diabetes occurrence in a mouse model.
A recent study found that longer telomeres in mice may shield them from age-related human diseases. Researchers used mice with shortened telomeres to examine a genetic defect causing an age-associated congenital heart disease in humans. The findings suggest that decreasing telomere length contributes to the onset of age-related diseases.
Acquired mutations in IDH enzyme help gliomas evade immune system activation by suppressing T cell recruitment. Inhibition of mutant IDH enhances vaccine-based immunotherapy treatment efficacy in glioma-bearing mice, suggesting potential for combinatorial therapies to counteract mutation effects.
Researchers have identified a key mechanism driving the emotional response to painful inflammation, highlighting potential therapeutic targets for managing chronic pain. Prostaglandins in brainstem serotonin-producing neurons play a crucial role in this process.
A study published in JCI reveals that mutant HTT protein and DISC1 form a complex that compromises its functions, leading to disruptions in downstream pathways. Normalizing the activity of this protein complex improves cognitive symptoms in HD mice, providing insights into DISC1's role in mental illness.
Research reveals rosiglitazone treatment increases brown fat genes in mice, reversing genetic alterations associated with obesity. The findings suggest environmental changes can reverse some genetic defects linked to type 2 diabetes.
Research suggests that stimulating GLP-1-producing neurons in the brain can control appetite and glucose levels. The study found that this stimulation reduced food intake and suppressed glucose generation in lean mice, but had no effect on obese mice.
Researchers identified a mutation in UNC13 protein associated with autism spectrum disorder, hyperactivity, and dyskinesia. The mutation disturbed fine-tuning of neuronal communication, leading to enhanced synaptic strength and increased neurotransmission.
Researchers have discovered a signaling pathway in cardiac tissue that helps control inflammatory responses after a heart attack. Activating the Hippo pathway leads to the recruitment of T regulatory cells, which reduce inflammation and promote tissue healing in mice with heart injury.
A study found that inhibiting CCR4 in a mouse model of renal cell carcinoma reduced tumor proliferation and changed the composition of immune cells. The results suggest anti-CCR4 antibodies as a potential therapeutic for multiple cancers linked to abnormal CCR4 expression.
A single episode of high fat intake caused immediate increases in fat accumulation and alterations in liver metabolism. Insulin resistance, elevated triglycerides, and increased glucagon levels were also observed.
Research by Waljit Dhillo at Imperial College London discovered that kisspeptin stimulates limbic brain areas associated with mood and emotion, influencing reproductive behavior. Kisspeptin treatment also enhanced brain activity during assessments of reward, drive, and mood in healthy heterosexual men.
Researchers developed a new PET imaging technique that can detect changes in olfactory neuron populations, which are sensitive to neurodevelopmental and neurodegenerative diseases. The technique uses GV1-57 radiotracer to quantify neuron generation and degeneration, providing insights into disease progression.
Researchers found that rapamycin treatment reduced proinflammatory cytokine release and toxicity without decreasing HIV-1 reactivation in T cells. The treatment did not impair the immune system's ability to recognize infected T cells, making it a potential strategy for targeting latent HIV-1 reservoirs.
Researchers have identified potential therapies for myotonic dystrophy type I (MD1) by targeting AMPK and mTORC1 pathways, which are disrupted in MD1 muscle tissue. Treatment with drugs that activate these pathways improves muscle function and reduces abnormal gene splicing.
Researchers discovered that two M1-selective medications reversed memory deficits and extended the lifespan of mice with neurodegenerative disease. The findings support the concept that more specific drugs can be effective in treating cognitive symptoms.
Research shows that blocking type I interferon signaling can enhance the effectiveness of antiretroviral therapy (cART) in HIV-infected mice. By targeting IFN-I signaling, antibodies were able to reduce chronic immune activation and viral load, leading to improved infection management.
Researchers investigated whether genetic variation in an immune system component called the complement system may contribute to vision loss during anti-VEGF therapy in wet AMD patients. Genetic variations were found to lead to complement system dysregulation, which was enhanced by blocking VEGF signaling.
Researchers discovered that targeting the TGF-β1 pathway can reduce pro-inflammatory signals and improve motor function in mice after intracerebral hemorrhage. In human patients, higher levels of TGF-β1 within the first 3 days following stroke predicted better outcomes three months into recovery.
A recent study found that metformin treatment inhibits abnormal mitochondrial metabolism and activates anti-proliferation signaling in individuals with Li-Fraumeni syndrome. This inhibition leads to lower rates of tumor formation and increased survival time, suggesting metformin as a potential strategy for cancer prevention.
A recent study published in JCI Journals reveals that immune cells, specifically perivascular macrophages, play a crucial role in the development of dementia in individuals with hypertension. The research suggests that targeting these cells may be a potential approach for preventing cognitive decline in high blood pressure patients.
Research suggests that obesity causes chronic inflammation in visceral adipose tissue, which leads to comorbid cardiovascular and metabolic diseases. A new study found that a specific T cell subtype associated with aging accumulates in obese mice, causing insulin resistance and obesity-like inflammation.
Researchers have developed a powerful screening method to identify drugs that more effectively target and kill pre-leukemic stem cells. By mimicking the bone marrow environment in a drug screening assay, they identified a compound called 2-methyoxyestradiol that reduces survival of pre-leukemic cells without affecting normal cells.
Research suggests that inhibiting autophagy can improve chemotherapy's immune-targeting effects without compromising overall immune system function. In mouse models, autophagy inhibitors did not disrupt the immune response to tumors during chemotherapy.
A new approach to treat cancer involves depleting CAR T cells after treatment, permanently restoring healthy B cell levels. Researchers created CD19-targeting CAR T cells with an additional EGFR targeting mechanism, eliminating tumors and reversing B cell aplasia in mice.
Tumor cells attract macrophages by releasing cytokines, which secrete growth factors that help tumor cells form spheroids and grow. Inhibiting these growth factors reduces tumor cell proliferation in a mouse model of ovarian cancer. This study sheds light on the early stages of ovarian tumor metastasis.
A recent study has identified a potential biomarker for assessing pancreatic tumor grade, which could improve diagnostic techniques and treatment strategies. Annexin 6-expressing vesicles were found to support increased tumor growth and metastasis in pancreatic ductal adenocarcinoma tumors.
A study published in JCI Insight found that age-related reductions of microRNA-155 may underlie age-associated hypertension. Mice lacking mineralocorticoid receptors in smooth muscle cells were protected from developing high blood pressure as they aged, and restoration of miR-155 improved blood pressure parameters.
Researchers found that platelet α6β1 integrin promotes interactions between tumor cells and platelets, leading to decreased lung metastasis in mice. Antibody-mediated blockade of α6β1 integrin inhibited tumor metastasis in murine models of breast cancer and melanoma.